ID SYI_COREF Reviewed; 1054 AA. AC Q8FNV0; DT 20-DEC-2005, integrated into UniProtKB/Swiss-Prot. DT 20-DEC-2005, sequence version 2. DT 24-JAN-2024, entry version 122. DE RecName: Full=Isoleucine--tRNA ligase {ECO:0000255|HAMAP-Rule:MF_02003}; DE EC=6.1.1.5 {ECO:0000255|HAMAP-Rule:MF_02003}; DE AltName: Full=Isoleucyl-tRNA synthetase {ECO:0000255|HAMAP-Rule:MF_02003}; DE Short=IleRS {ECO:0000255|HAMAP-Rule:MF_02003}; GN Name=ileS {ECO:0000255|HAMAP-Rule:MF_02003}; OrderedLocusNames=CE2043; OS Corynebacterium efficiens (strain DSM 44549 / YS-314 / AJ 12310 / JCM 11189 OS / NBRC 100395). OC Bacteria; Actinomycetota; Actinomycetes; Mycobacteriales; OC Corynebacteriaceae; Corynebacterium. OX NCBI_TaxID=196164; RN [1] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RC STRAIN=DSM 44549 / YS-314 / AJ 12310 / JCM 11189 / NBRC 100395; RX PubMed=12840036; DOI=10.1101/gr.1285603; RA Nishio Y., Nakamura Y., Kawarabayasi Y., Usuda Y., Kimura E., Sugimoto S., RA Matsui K., Yamagishi A., Kikuchi H., Ikeo K., Gojobori T.; RT "Comparative complete genome sequence analysis of the amino acid RT replacements responsible for the thermostability of Corynebacterium RT efficiens."; RL Genome Res. 13:1572-1579(2003). CC -!- FUNCTION: Catalyzes the attachment of isoleucine to tRNA(Ile). As IleRS CC can inadvertently accommodate and process structurally similar amino CC acids such as valine, to avoid such errors it has two additional CC distinct tRNA(Ile)-dependent editing activities. One activity is CC designated as 'pretransfer' editing and involves the hydrolysis of CC activated Val-AMP. The other activity is designated 'posttransfer' CC editing and involves deacylation of mischarged Val-tRNA(Ile). CC {ECO:0000255|HAMAP-Rule:MF_02003}. CC -!- CATALYTIC ACTIVITY: CC Reaction=ATP + L-isoleucine + tRNA(Ile) = AMP + diphosphate + L- CC isoleucyl-tRNA(Ile); Xref=Rhea:RHEA:11060, Rhea:RHEA-COMP:9666, CC Rhea:RHEA-COMP:9695, ChEBI:CHEBI:30616, ChEBI:CHEBI:33019, CC ChEBI:CHEBI:58045, ChEBI:CHEBI:78442, ChEBI:CHEBI:78528, CC ChEBI:CHEBI:456215; EC=6.1.1.5; Evidence={ECO:0000255|HAMAP- CC Rule:MF_02003}; CC -!- COFACTOR: CC Name=Zn(2+); Xref=ChEBI:CHEBI:29105; Evidence={ECO:0000255|HAMAP- CC Rule:MF_02003}; CC -!- SUBUNIT: Monomer. {ECO:0000255|HAMAP-Rule:MF_02003}. CC -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000255|HAMAP-Rule:MF_02003}. CC -!- DOMAIN: IleRS has two distinct active sites: one for aminoacylation and CC one for editing. The misactivated valine is translocated from the CC active site to the editing site, which sterically excludes the CC correctly activated isoleucine. The single editing site contains two CC valyl binding pockets, one specific for each substrate (Val-AMP or Val- CC tRNA(Ile)). {ECO:0000255|HAMAP-Rule:MF_02003}. CC -!- SIMILARITY: Belongs to the class-I aminoacyl-tRNA synthetase family. CC IleS type 2 subfamily. {ECO:0000255|HAMAP-Rule:MF_02003}. CC -!- SEQUENCE CAUTION: CC Sequence=BAC18853.1; Type=Erroneous initiation; Evidence={ECO:0000305}; CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; BA000035; BAC18853.1; ALT_INIT; Genomic_DNA. DR RefSeq; WP_011075728.1; NZ_GG700683.1. DR AlphaFoldDB; Q8FNV0; -. DR SMR; Q8FNV0; -. DR STRING; 196164.gene:10742471; -. DR KEGG; cef:CE2043; -. DR eggNOG; COG0060; Bacteria. DR HOGENOM; CLU_001493_1_1_11; -. DR OrthoDB; 9810365at2; -. DR Proteomes; UP000001409; Chromosome. DR GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell. DR GO; GO:0002161; F:aminoacyl-tRNA editing activity; IEA:InterPro. DR GO; GO:0005524; F:ATP binding; IEA:UniProtKB-UniRule. DR GO; GO:0004822; F:isoleucine-tRNA ligase activity; IEA:UniProtKB-UniRule. DR GO; GO:0000049; F:tRNA binding; IEA:InterPro. DR GO; GO:0008270; F:zinc ion binding; IEA:UniProtKB-UniRule. DR GO; GO:0006428; P:isoleucyl-tRNA aminoacylation; IEA:UniProtKB-UniRule. DR CDD; cd07961; Anticodon_Ia_Ile_ABEc; 1. DR CDD; cd00818; IleRS_core; 1. DR Gene3D; 3.40.50.620; HUPs; 2. DR HAMAP; MF_02003; Ile_tRNA_synth_type2; 1. DR InterPro; IPR001412; aa-tRNA-synth_I_CS. DR InterPro; IPR002300; aa-tRNA-synth_Ia. DR InterPro; IPR033709; Anticodon_Ile_ABEc. DR InterPro; IPR002301; Ile-tRNA-ligase. DR InterPro; IPR023586; Ile-tRNA-ligase_type2. DR InterPro; IPR013155; M/V/L/I-tRNA-synth_anticd-bd. DR InterPro; IPR014729; Rossmann-like_a/b/a_fold. DR InterPro; IPR009080; tRNAsynth_Ia_anticodon-bd. DR InterPro; IPR009008; Val/Leu/Ile-tRNA-synth_edit. DR NCBIfam; TIGR00392; ileS; 1. DR PANTHER; PTHR42780:SF1; ISOLEUCINE--TRNA LIGASE, CYTOPLASMIC; 1. DR PANTHER; PTHR42780; SOLEUCYL-TRNA SYNTHETASE; 1. DR Pfam; PF08264; Anticodon_1; 1. DR Pfam; PF19302; DUF5915; 1. DR Pfam; PF00133; tRNA-synt_1; 1. DR PRINTS; PR00984; TRNASYNTHILE. DR SUPFAM; SSF47323; Anticodon-binding domain of a subclass of class I aminoacyl-tRNA synthetases; 1. DR SUPFAM; SSF52374; Nucleotidylyl transferase; 1. DR SUPFAM; SSF50677; ValRS/IleRS/LeuRS editing domain; 1. DR PROSITE; PS00178; AA_TRNA_LIGASE_I; 1. PE 3: Inferred from homology; KW Aminoacyl-tRNA synthetase; ATP-binding; Cytoplasm; Ligase; Metal-binding; KW Nucleotide-binding; Protein biosynthesis; Reference proteome; Zinc. FT CHAIN 1..1054 FT /note="Isoleucine--tRNA ligase" FT /id="PRO_0000098537" FT MOTIF 58..68 FT /note="'HIGH' region" FT MOTIF 627..631 FT /note="'KMSKS' region" FT BINDING 630 FT /ligand="ATP" FT /ligand_id="ChEBI:CHEBI:30616" FT /evidence="ECO:0000255|HAMAP-Rule:MF_02003" SQ SEQUENCE 1054 AA; 118226 MW; 17924A0E38AF555F CRC64; MTEAVGGVYP LVDMTGGSSR FPEMEENVLD FWKRDDTFQA SIDQRNDAED YVFYDGPPFA NGLPHYGHLL TGYVKDIVPR YQTMRGYRVP RVFGWDTHGL PAELEAEKQL GIKDKGEIES MGLAQFNDYC AKSVLQYTKE WEEYVTRQAR WVDFENGYKT MDLTYMESVI WAFKELYDKG LIYQGFRVLP YSWAEHTPLS NQETRLDDSY KMRQDPTLTV TMPITGKIEG TGANEALIGA NAIAWTTTPW TLPSNLALAV NPSVTYALVE VAGDGEEGFV GQQLLLARDL VGAYAKELGT DARIISEHPG TELIGLTYEP VFDFFRDHPN AFQILGADYV TTEDGTGIVH QAPAFGEDDM NVCNAADIAP VIPVDMDGKF TSLTPEYEGQ LVFDANKDII RDLKAKGRVF RHQTIEHSYP HSWRSGEPLI YMALPSWFVN VTKIRDRMVE TNQDIEWMPA HIRDGQFGKW LEGARDWNIS RSRYWGSPIP VWVSDDENYP RVDVYGSLDE LEADFGVRPT SLHRPYIDEL TRPNPDDPTG KSTMRRVPDV LDVWFDSGSM PFAQVHYPFE NKDWFDTHAP ADFIVEYIGQ TRGWFYLLHV LSVGLFDRPA FKKVVAHGIV LGDDGLKMSK SKGNYPNVTE VFDRDGSDAM RWFLMSSPIL RGGNLIVTEK GIREGVRQAQ LPMWNAYSFL QLYASKKATW SVDSTDVLDR YILAKLHDLV ADVTAALDAT DIARACDQVR WFCDALTNWY VRRSRDRFWA GDEAHPEAFN TLYTVLETLT RVAAPLLPMT TEVIWRGLTG ERSVHLTDFP SADSFPADAD LVRTMDEIRG VCSAASSIRK AHKLRNRLPL PNLTVALPDS GRLADFLSII RDEVNVKNVD LTSDVDAVGT FEVVVNAKVA GPRLGKDVQR VIKAVKAGNY ERVGETVVAD GIELQDGEYT ERLVAANPDS TAQIDDVDGL VVLDMEVTPE LEAEGWAADV IRGLQDARKS SGFEVSDRIQ VTLSVPGDKQ EWATRHADHI AGEVLATSFE VTQDDLGEDA HEVLKGVTAS VARV //